SI
AKRO

Sofinnova Investments’s Akero Therapeutics AKRO Stock Holding History

Sofinnova Investments’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150,000
Closed -$3.18M – 78
2020
Q1 		$3.18M Buy
+150,000
New +$3.22M 0.29% 43

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sofinnova Investments's AKRO Position: Q4 2025 in Review

Sofinnova Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 473,625 shares — an estimated $22.5M sold.

Sofinnova Investments first reported a position in AKRO in Q1 2020 and held it in 4 quarters. The position peaked at $29.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Sofinnova Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Sofinnova Investments sold 473,625 Akero Therapeutics shares in Q4 2025, an estimated $22.5M.
  • Sofinnova Investments first reported a position in Akero Therapeutics in Q1 2020 and held it in 4 quarters.
  • Sofinnova Investments's Akero Therapeutics position peaked at $29.3M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Sofinnova Investments's 13F filing for Q4 2025, filed 13 Feb 2026.